8
Oct
2024

Avema Pharma Solutions

Exhibitor at CPHI Milan 2024 stand 22G36, Integrated Pharma
About Us

Avéma Pharma Solutions is a true CDMO for Rx and OTC supporting your product from concept to commercialization. We develop and manufacture oral liquid dose and solid dose units, including: suspensions, solutions, tablets and capsules. Delivery technologies include:

  • immediate release systems,
  • modified release systems, 
  • delayed-release and extended-release, 
  • chewable tablets,
  • quick dissolve tablets,
  • two-piece hard-shell capsules and taste masking, 
  • extended release using
...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • US
  • 2017
    On CPHI since
  • 1
    Certificates
Company types
Contract Service
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 22G36, Integrated Pharma

Products Featured at CPHI Milan 2024

  • Solid & Liquid Dose Drug Manufacturing & Development

    Product Solid & Liquid Dose Drug Manufacturing & Development

    From OTC and Rx to diagnostics and dietary supplements, Avéma manufactures a full range of solid and liquid dose products, all manufactured under strict FDA guidelines and cGMP compliance. With an ever-growing portfolio of innovative formulas and a diverse mix of state-of-the-art equipment, our offerings a...
  • Research & Development

    Product Research & Development

    Avéma offers formulation, process and analytical development support of new or existing products using the most current and effective active ingredients and delivery systems. Our team of scientists bring decades of pre-formulation development expertise to your products, combined with the knowledge of how t...
  • ANDA and NDA Technical Support

    Product ANDA and NDA Technical Support

    As part of its commitment to full service support, Avéma Contract Services is pleased to offer our customers support with ANDA and NDA applications, including bio equivalency studies, collecting background data, supervising technology tranfers and reviewing applications to make sure that companies com...
  • Commercial Manufacturing

    Product Commercial Manufacturing

    Covering a 135,000ft² area, our Miami facility is registered with the FDA and complies fully with current good manufacturing practice (cGMP) guidelines. It has the capacity for R&D, process development and small-scale launches, including pilot-scale cGMP manufacturing and packaging to support pilot pharmac...
  • Formulation Development

    Product Formulation Development

    Avéma has an extensive library of formulations and more than 40 years of Rx formulation development experience.